Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Eur J Surg Oncol
    September 2022
  1. NAGASAWA S, Sato T, Morita J, Kondo H, et al
    Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer.
    Eur J Surg Oncol. 2022 Sep 9. pii: S0748-7983(22)00654.
    >> Share

    August 2022
  2. LI Y, Chen X, Ma X, Lu X, et al
    Computed tomography in the size measurement of gastric gastrointestinal stromal tumors: Implication to risk stratification and "wait-and-see" tactics.
    Eur J Surg Oncol. 2022;48:1739-1745.
    >> Share

    July 2022
  3. CHEN QY, Que SJ, Chen JY, Qing-Zhong, et al
    Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
    Eur J Surg Oncol. 2022 Jul 14. pii: S0748-7983(22)00521.
    >> Share

  4. HAJJAR R, Mercier F, Passot G, Pasquer A, et al
    Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis.
    Eur J Surg Oncol. 2022;48:1626-1630.
    >> Share

    June 2022
  5. WANG L, Lv P, Xue Z, Chen L, et al
    Novel CT based clinical nomogram comparable to radiomics model for identification of occult peritoneal metastasis in advanced gastric cancer.
    Eur J Surg Oncol. 2022 Jun 30. pii: S0748-7983(22)00539.
    >> Share

  6. CHEN Y, Sun R, Liu W
    Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study.
    Eur J Surg Oncol. 2022 Jun 20. pii: S0748-7983(22)00524.
    >> Share

  7. CHEN JY, Lin GT, Chen QY, Zhong Q, et al
    Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis.
    Eur J Surg Oncol. 2022 Jun 9. pii: S0748-7983(22)00475.
    >> Share

  8. SONG JH, Shin HJ, Lee S, Park SH, et al
    No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis.
    Eur J Surg Oncol. 2022 Jun 1. pii: S0748-7983(22)00476.
    >> Share

    May 2022
  9. JEONG SA, Yoo MW, Lee IS, Gong CS, et al
    Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: A retrospective study with propensity score matching.
    Eur J Surg Oncol. 2022 May 23. pii: S0748-7983(22)00464.
    >> Share

  10. ARGILLANDER TE, Festen S, van der Zaag-Loonen HJ, de Graeff P, et al
    Outcomes of surgical treatment of non-metastatic gastric cancer in patients aged 70 and older: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022 May 16. pii: S0748-7983(22)00428.
    >> Share

  11. EVANS RP, Kamarajah SK, Kunene V, Zardo D, et al
    Impact of neoadjuvant chemotherapy on nodal regression and survival in oesophageal adenocarcinoma.
    Eur J Surg Oncol. 2022;48:1001-1010.
    >> Share

  12. SPOLVERATO G, Azzolina D, Paro A, Lorenzoni G, et al
    Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis.
    Eur J Surg Oncol. 2022;48:1025-1032.
    >> Share

    April 2022
  13. LEE TY, Hsu CH, Fan HL, Liao GS, et al
    Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00413.
    >> Share

    March 2022
  14. HAYASHI T, Yoshikawa T
    Reply to: Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients diagnosed as pT1b gastric cancer by endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 25. pii: S0748-7983(22)00155.
    >> Share

  15. MATSUI R, Rifu K, Watanabe J, Inaki N, et al
    Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for patients diagnosed with pT1b gastric cancer via endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00132.
    >> Share

  16. DENG H, Qin X
    Comment on Granieri et al. "Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials".
    Eur J Surg Oncol. 2022 Mar 12. pii: S0748-7983(22)00122.
    >> Share

  17. LU J, Wu D, Chen S, Huang JB, et al
    A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis.
    Eur J Surg Oncol. 2022 Mar 5. pii: S0748-7983(22)00044.
    >> Share

  18. KAMIYA A, Yoshikawa T, Sakon R, Ishizu K, et al
    Optimal surgery and lymph node metastasis of duodenal bulbar neuroendocrine neoplasms.
    Eur J Surg Oncol. 2022;48:597-603.
    >> Share

  19. VAN DER WIELEN N, Daams F, Rosati R, Parise P, et al
    Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial.
    Eur J Surg Oncol. 2022;48:553-560.
    >> Share

    February 2022
  20. QIU WW, Chen QY, Zheng WZ, He QC, et al
    Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence time.
    Eur J Surg Oncol. 2022 Feb 25. pii: S0748-7983(22)00119.
    >> Share

  21. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    >> Share

  22. CHOI M, Ishizawa S, Kraemer D, Sasson A, et al
    Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis.
    Eur J Surg Oncol. 2022;48:403-410.
    >> Share

  23. OH SE, Lee GH, An JY, Lee JH, et al
    Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Eur J Surg Oncol. 2022;48:370-376.
    >> Share

  24. LUIJTEN JCHBM, Nieuwenhuijzen GAP, Sosef MN, de Hingh IHJT, et al
    Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in the Netherlands.
    Eur J Surg Oncol. 2022;48:348-355.
    >> Share

  25. HAYASHI T, Yoshikawa T, Ishizu K, Tsutsui M, et al
    Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients who diagnosed as pT1b gastric cancer by endoscopic resection.
    Eur J Surg Oncol. 2022 Feb 1. pii: S0748-7983(22)00072.
    >> Share

    January 2022
  26. SOLAINI L, Bencivenga M, D'ignazio A, Milone M, et al
    Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study.
    Eur J Surg Oncol. 2022 Jan 22. pii: S0748-7983(22)00046.
    >> Share

  27. TERASHIMA M, Sano T, Mizusawa J, Umemura K, et al
    Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110.
    Eur J Surg Oncol. 2022 Jan 19. pii: S0748-7983(22)00040.
    >> Share

  28. YASUFUKU I, Ohashi M, Makuuchi R, Hayami M, et al
    High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy.
    Eur J Surg Oncol. 2022 Jan 11. pii: S0748-7983(22)00012.
    >> Share

  29. TAKEBAYASHI K, Murata S, Kodama H, Kaida S, et al
    Long-term prognosis of patients with cancer-related genes detected in postoperative peritoneal washings obtained during curative gastrectomy.
    Eur J Surg Oncol. 2022;48:177-182.
    >> Share

    December 2021
  30. CERO MD, Rodriguez-Santiago J, Miro M, Castro S, et al
    Evaluation of data quality in the Spanish EURECCA Esophagogastric Cancer Registry.
    Eur J Surg Oncol. 2021;47:3081-3087.
    >> Share

    November 2021
  31. QIU Y, Zhang X, Deng X, Zhang R, et al
    Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
    Eur J Surg Oncol. 2021 Nov 21. pii: S0748-7983(21)00924.
    >> Share

  32. HUANG SF, Chen TC, Hsu JT, Tsai CY, et al
    Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm.
    Eur J Surg Oncol. 2021 Nov 19. pii: S0748-7983(21)00926.
    >> Share

  33. DAL CERO M, Roman M, Grande L, Yarnoz C, et al
    Textbook outcome and survival after gastric cancer resection with curative intent: A population-based analysis.
    Eur J Surg Oncol. 2021 Nov 2. pii: S0748-7983(21)00775.
    >> Share

    September 2021
  34. ROVIELLO F, Marano L, Ambrosio MR, Resca L, et al
    Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival.
    Eur J Surg Oncol. 2021 Sep 7. pii: S0748-7983(21)00726.
    >> Share

    August 2021
  35. JAVANBAKHT M, Mashayekhi A, Branagan-Harris M, Horvath P, et al
    Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Eur J Surg Oncol. 2021 Aug 28. pii: S0748-7983(21)00696.
    >> Share

  36. PARK JH, Berlth F, Wang C, Wang S, et al
    Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 27. pii: S0748-7983(21)00701.
    >> Share

  37. ZHANG FM, Zhang XZ, Zhu GL, Lv LQ, et al
    Impact of sarcopenia on clinical outcomes of patients with stage I gastric cancer after radical gastrectomy: A prospective cohort study.
    Eur J Surg Oncol. 2021 Aug 17. pii: S0748-7983(21)00693.
    >> Share

  38. SEDLAK K, Rawicz-Pruszynski K, Mlak R, Geca K, et al
    Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
    Eur J Surg Oncol. 2021 Aug 11. pii: S0748-7983(21)00674.
    >> Share

  39. RI M, Yamashita H, Gonoi W, Okumura Y, et al
    Identifying multiple swollen lymph nodes on preoperative computed tomography is associated with poor prognosis along with pathological extensive nodal metastasis in locally advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 10. pii: S0748-7983(21)00687.
    >> Share

  40. BORGSTEIN ABJ, Keywani K, Eshuis WJ, van Berge Henegouwen MI, et al
    Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study.
    Eur J Surg Oncol. 2021 Aug 8. pii: S0748-7983(21)00672.
    >> Share

  41. CHALLINE A, Voron T, Dousset B, Creavin B, et al
    Postoperative outcomes after laparoscopic or open gastrectomy. A national cohort study of 10,343 patients.
    Eur J Surg Oncol. 2021;47:1985-1995.
    >> Share

  42. ZOU HB, Yan XL, Dong WX, Yu DY, et al
    Sarcopenia is a predictive factor of poor quality of life and prognosis in patients after radical gastrectomy.
    Eur J Surg Oncol. 2021;47:1976-1984.
    >> Share

  43. YAMAGATA Y, Yoshikawa T, Ishizu K, Kamiya A, et al
    Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
    Eur J Surg Oncol. 2021;47:2004-2009.
    >> Share

  44. HAYASHI M, Fujita T, Matsushita H
    Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
    Eur J Surg Oncol. 2021;47:1996-2003.
    >> Share

    July 2021
  45. CHEN Y, Yuan F, Wang L, Li E, et al
    Evaluation of dual-energy CT derived radiomics signatures in predicting outcomes in patients with advanced gastric cancer after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 20. pii: S0748-7983(21)00635.
    >> Share

  46. WADA T, Yoshikawa T, Sekine S, Kamiya A, et al
    Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 17. pii: S0748-7983(21)00637.
    >> Share

  47. KACMAZ E, Slooter MD, Nieveen van Dijkum EJM, Tanis PJ, et al
    Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
    Eur J Surg Oncol. 2021;47:1611-1615.
    >> Share

    June 2021
  48. ROH CK, Hyung WJ
    Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 9. pii: S0748-7983(21)00543.
    >> Share

  49. CARBONI F, Valle M
    Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 5. pii: S0748-7983(21)00544.
    >> Share

  50. BARCOT O, Boric M, Cavar M, Poropat G, et al
    Predictive value of abdominal drain amylase for postoperative pancreatic fistula following gastric resection: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:1244-1251.
    >> Share

    May 2021
  51. GRANIERI S, Bonomi A, Frassini S, Chierici AP, et al
    Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2021 May 11. pii: S0748-7983(21)00492.
    >> Share

    April 2021
  52. LIN YC, Lin G, Yeh TS
    Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer----- highlighting the role of adiponectin receptors and PPARalpha, beta/ delta, .
    Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00456.
    >> Share

  53. OH YJ, Kim DH, Han WH, Eom BW, et al
    Risk factors for lymph node metastasis in early gastric cancer without lymphatic invasion after endoscopic submucosal dissection.
    Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00457.
    >> Share

  54. KANO Y, Ohashi M, Muneoka Y, Takahari D, et al
    Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00446.
    >> Share

  55. FAIZ Z, Hayashi T, Yoshikawa T
    Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00447.
    >> Share

  56. KIM DG, Seo WJ, Cho M, Kim YM, et al
    Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00445.
    >> Share

  57. CHEN XD, He FQ, Liao MS, Chen M, et al
    Laparoscopic versus open transhiatal approach for adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:778-788.
    >> Share

    March 2021
  58. BOLGER JC, Al Azzawi M, Whooley J, Bolger EM, et al
    Surgery by a minimally invasive approach is associated with improved textbook outcomes in oesophageal and gastric cancer.
    Eur J Surg Oncol. 2021 Mar 17. pii: S0748-7983(21)00381.
    >> Share

  59. LEE KG, Shin CI, Kim SG, Choi J, et al
    Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer?
    Eur J Surg Oncol. 2021 Mar 10. pii: S0748-7983(21)00125.
    >> Share

  60. HUANG DD, Yu DY, Song HN, Wang WB, et al
    The relationship between the GLIM-defined malnutrition, body composition and functional parameters, and clinical outcomes in elderly patients undergoing radical gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2021 Mar 6. pii: S0748-7983(21)00126.
    >> Share

    February 2021
  61. ROH CK, Choi S, Seo WJ, Cho M, et al
    Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre.
    Eur J Surg Oncol. 2021 Feb 25. pii: S0748-7983(21)00104.
    >> Share

  62. MURNANE LC, Forsyth AK, Koukounaras J, Pilgrim CH, et al
    Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery.
    Eur J Surg Oncol. 2021 Feb 19. pii: S0748-7983(21)00099.
    >> Share

  63. WEN L, Yu K, Lu H, Zhong G, et al
    Impact of prior cancer history on survival of patients with gastric cancer.
    Eur J Surg Oncol. 2021 Feb 11. pii: S0748-7983(21)00090.
    >> Share

  64. XING J, Wang Y, Shan F, Li S, et al
    Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Eur J Surg Oncol. 2021 Feb 6. pii: S0748-7983(21)00085.
    >> Share

    January 2021
  65. KOSEKI Y, Hikage M, Fujiya K, Kamiya S, et al
    Utility of a modified age-adjusted Charlson Comorbidity Index in predicting cause-specific survival among patients with gastric cancer.
    Eur J Surg Oncol. 2021 Jan 30. pii: S0748-7983(21)00056.
    >> Share

    December 2020
  66. JI ZH, Yu Y, Liu G, Zhang YB, et al
    Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Eur J Surg Oncol. 2020 Dec 1. pii: S0748-7983(20)31035.
    >> Share

  67. KOEMANS WJ, van Sandick JW, Huitema ADR
    Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy".
    Eur J Surg Oncol. 2020;46:2343.
    >> Share

    November 2020
  68. OSORIO J, Jerico C, Miranda C, Santamaria M, et al
    Improved postoperative outcomes and reduced transfusion rates after implementation of a Patient Blood Management program in gastric cancer surgery.
    Eur J Surg Oncol. 2020 Nov 27. pii: S0748-7983(20)31025.
    >> Share

  69. KINOSHITA T, Sato R, Akimoto E, Yoshida M, et al
    Can laparoscopic spleen-preserving splenic hilar lymph node dissection replace prophylactic splenectomy for proximal advanced gastric cancers that invade the greater curvature?
    Eur J Surg Oncol. 2020 Nov 26. pii: S0748-7983(20)31029.
    >> Share

  70. WANG L, Gong J, Huang X, Lin G, et al
    CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer.
    Eur J Surg Oncol. 2020 Nov 24. pii: S0748-7983(20)31028.
    >> Share

  71. BORGSTEIN ABJ, van Berge Henegouwen MI, Lameris W, Eshuis WJ, et al
    Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent.
    Eur J Surg Oncol. 2020 Nov 17. pii: S0748-7983(20)30903.
    >> Share

    October 2020
  72. NISHIWAKI N, Irino T, Fujiya K, Kamiya S, et al
    Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer.
    Eur J Surg Oncol. 2020 Oct 23. pii: S0748-7983(20)30860.
    >> Share

  73. GERTSEN EC, Brenkman HJF, Brosens LAA, Luijten JCHBM, et al
    Refraining from resection in patients with potentially curable gastric carcinoma.
    Eur J Surg Oncol. 2020 Oct 22. pii: S0748-7983(20)30862.
    >> Share

  74. BENCIVENGA M, Torroni L, Verlato G, Mengardo V, et al
    Lymphadenectomy for gastric cancer at European specialist centres.
    Eur J Surg Oncol. 2020 Oct 15. pii: S0748-7983(20)30845.
    >> Share

  75. BRANDL A, Yonemura Y, Glehen O, Sugarbaker P, et al
    Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
    Eur J Surg Oncol. 2020 Oct 14. pii: S0748-7983(20)30839.
    >> Share

  76. ZHANG Z, Cheng S, Gong J, Lu M, et al
    Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
    Eur J Surg Oncol. 2020;46.
    >> Share

  77. REN C, Xu RH
    The drug treatment research of gastrointestinal cancer in China.
    Eur J Surg Oncol. 2020;46.
    >> Share

    August 2020
  78. TU RH, Lin JX, Wang W, Li P, et al
    Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with
    Eur J Surg Oncol. 2020 Aug 10. pii: S0748-7983(20)30574.
    >> Share

  79. KOEMANS WJ, van der Kaaij RT, Wassenaar ECE, Grootscholten C, et al
    Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy.
    Eur J Surg Oncol. 2020 Aug 5. pii: S0748-7983(20)30664.
    >> Share

  80. WEINDELMAYER J, Mengardo V, Veltri A, Torroni L, et al
    Should we still use prophylactic drain in gastrectomy for cancer? A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46:1396-1403.
    >> Share

  81. DEFTEREOS I, Kiss N, Isenring E, Carter VM, et al
    A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection.
    Eur J Surg Oncol. 2020;46:1423-1434.
    >> Share

    July 2020
  82. XU LB, Zhang HH, Shi MM, Huang ZX, et al
    Metabolic syndrome-related sarcopenia is associated with worse prognosis in patients with gastric cancer: A prospective study.
    Eur J Surg Oncol. 2020 Jul 29. pii: S0748-7983(20)30659.
    >> Share

  83. KOTA I, Makoto H, Satoshi K, Yutaka T, et al
    Oncologic feasibility of D1+ gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer.
    Eur J Surg Oncol. 2020 Jul 27. pii: S0748-7983(20)30658.
    >> Share

  84. CHEN QY, Zhong Q, Liu ZY, Huang XB, et al
    Advances in laparoscopic surgery for the treatment of advanced gastric cancer in China.
    Eur J Surg Oncol. 2020 Jul 17. pii: S0748-7983(20)30641.
    >> Share

  85. FURUKAWA K, Kamiya S, Sugino T, Aizawa D, et al
    Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin.
    Eur J Surg Oncol. 2020 Jul 15. pii: S0748-7983(20)30575.
    >> Share

  86. CHEN X, Feng X, Wang M, Yao X, et al
    Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.
    Eur J Surg Oncol. 2020 Jul 11. pii: S0748-7983(20)30572.
    >> Share

  87. TRAPANI R, Rausei S, Reddavid R, Degiuli M, et al
    Risk factors for esophago-jejunal anastomosis leakage after total gastrectomy for cancer. A multicenter retrospective study of the Italian research group for gastric cancer.
    Eur J Surg Oncol. 2020 Jul 9. pii: S0748-7983(20)30560.
    >> Share

  88. WANG P, Deng J, Sun Z, Wang W, et al
    Proposal of a novel subclassification of pN3b for improvement the prognostic discrimination ability of gastric cancer patients.
    Eur J Surg Oncol. 2020 Jul 4. pii: S0748-7983(20)30558.
    >> Share

    June 2020
  89. WANG X, Sun J, Zhang W, Yang X, et al
    Use of radiomics to extract splenic features to predict prognosis of patients with gastric cancer.
    Eur J Surg Oncol. 2020 Jun 27. pii: S0748-7983(20)30545.
    >> Share

  90. ZHU Z, Gong Y, Xu H
    Clinical and pathological staging of gastric cancer: Current perspectives and implications.
    Eur J Surg Oncol. 2020 Jun 24. pii: S0748-7983(20)30526.
    >> Share

  91. GONG Y, Pan S, Wang X, Zhu G, et al
    A novel lymph node staging system for gastric cancer including modified Union for cancer Control/American Joint Committee on cancer and Japanese Gastric Cancer Association criteria.
    Eur J Surg Oncol. 2020 Jun 23. pii: S0748-7983(20)30525.
    >> Share

  92. OH SE, An JY, Choi MG, Lee JH, et al
    Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.
    Eur J Surg Oncol. 2020 Jun 20. pii: S0748-7983(20)30557.
    >> Share

  93. ALYAMI M, Bonnot PE, Mercier F, Laplace N, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Eur J Surg Oncol. 2020 Jun 9. pii: S0748-7983(20)30495.
    >> Share

  94. FUJIYA K, Ohshima K, Kitagawa Y, Hatakeyama K, et al
    Aberrant expression of Wnt/beta-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2020;46:1080-1087.
    >> Share

    May 2020
  95. TEE MC, Pirozzi N, Brahmbhatt RD, Raman S, et al
    Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
    Eur J Surg Oncol. 2020 May 16. pii: S0748-7983(20)30486.
    >> Share

  96. KAMBARA Y, Miyake H, Nagai H, Yoshioka Y, et al
    CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
    Eur J Surg Oncol. 2020 May 16. pii: S0748-7983(20)30456.
    >> Share

  97. SUGAWARA K, Yamashita H, Urabe M, Okumura Y, et al
    Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery.
    Eur J Surg Oncol. 2020 May 4. pii: S0748-7983(20)30441.
    >> Share

    April 2020
  98. HAN WH, Oh YJ, Eom BW, Yoon HM, et al
    Prognostic impact of infectious complications after curative gastric cancer surgery.
    Eur J Surg Oncol. 2020 Apr 23. pii: S0748-7983(20)30429.
    >> Share

  99. KANG JH, Ryu SY, Jung MR, Jeong O, et al
    Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for >/= pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Eur J Surg Oncol. 2020 Apr 14. pii: S0748-7983(20)30410.
    >> Share

  100. GERTSEN EC, de Jongh C, Brenkman HJF, Mertens AC, et al
    The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer.
    Eur J Surg Oncol. 2020 Apr 14. pii: S0748-7983(20)30399.
    >> Share

  101. ARCHID R, Zieker D, Weinreich FJ, Hones F, et al
    shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
    Eur J Surg Oncol. 2020;46.
    >> Share

  102. WANG C, Gao Z, Shen K, Cao J, et al
    Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46.
    >> Share

  103. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
    Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Eur J Surg Oncol. 2020;46.
    >> Share

  104. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
    Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Eur J Surg Oncol. 2020;46.
    >> Share

    March 2020
  105. YANG W, Xia F, Wang J, Zhou M, et al
    Quantifying skeletal muscle wasting during chemoradiotherapy with Jacobian calculations for the prediction of survival and toxicity in patients with gastric cancer.
    Eur J Surg Oncol. 2020 Mar 31. pii: S0748-7983(20)30390.
    >> Share

  106. OH SE, An JY, Choi MG, Sohn TS, et al
    Long term oncological outcome of patients with grossly early gastric cancer-mimicking advanced gastric cancer.
    Eur J Surg Oncol. 2020 Mar 18. pii: S0748-7983(20)30352.
    >> Share

  107. SATO Y, Mizusawa J, Katayama H, Nakamura K, et al
    Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A.
    Eur J Surg Oncol. 2020 Mar 4. pii: S0748-7983(20)30145.
    >> Share

    January 2020
  108. DIAS AR, Pereira MA, Ramos MFKP, Oliveira RJ, et al
    Prediction scores for complication and recurrence after multivisceral resection in gastric cancer.
    Eur J Surg Oncol. 2020 Jan 11. pii: S0748-7983(20)30018.
    >> Share

  109. LU H, Zhao B, Zhang J, Huang R, et al
    Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30017.
    >> Share

  110. WANG JB, Liu ZY, Huang XB, Chen QY, et al
    Implications for restaging in gastric cancer with peritoneal metastasis based on the 15th Japanese Classification of Gastric Carcinoma: An analysis from a comprehensive center.
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30016.
    >> Share

    December 2019
  111. KARSTENS KF, Ghadban T, Sawez S, Konczalla L, et al
    Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Eur J Surg Oncol. 2019 Dec 14. pii: S0748-7983(19)31504.
    >> Share

    October 2019
  112. PARK SH, Lee S, Song JH, Choi S, et al
    Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.
    Eur J Surg Oncol. 2019 Oct 18. pii: S0748-7983(19)30904.
    >> Share

    September 2019
  113. JEONG SH, Kim RB, Park SY, Park J, et al
    Nomogram for predicting gastric cancer recurrence using biomarker gene expression.
    Eur J Surg Oncol. 2019 Sep 21. pii: S0748-7983(19)30809.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016